Archive for the Sirona Biochem Category

Sirona Biochem Announces Positive Efficacy Results for Skin Lightening Library

Sirona Biochem Announces Positive Efficacy Results for Skin Lightening Library

Sirona Biochem Announces Positive Efficacy Results for Skin Lightening Library   Momentum Public Relations Press Release: July 6, 2017 VANCOUVER, BC–(Marketwired – July 06, 2017) – Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB)(XETRA: ZSB) (the “Company“) announced positive preclinical efficacy data for its library of skin lightening compounds. The study was […]

Read more

The Fountain of Youth May Be Just Around the Corner In Vancouver

The Fountain of Youth May Be Just Around the Corner In Vancouver

The Fountain of Youth May Be Just Around the Corner In Vancouver   Sirona Biochem makes safer and more effective cosmeceuticals     Vancouver-based Sirona Biochem is on track to crack the global market for skin lightening products, a market that has been predicted by Global Industry […]

Read more

Sirona Biochem Closes Convertible Note Financing

Sirona Biochem Closes Convertible Note Financing

  Sirona Biochem Closes Convertible Note Financing   Momentum Public Relations Press Release: June 5, 2017 VANCOUVER, BC–(Marketwired – June 05, 2017) – Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB)(XETRA: ZSB) is pleased to announce that it has closed the non-brokered private placement (the “Private Placement”) of […]

Read more

Sirona Biochem Announces Convertible Note Financing

Sirona Biochem Announces Convertible Note Financing

  Sirona Biochem Announces Convertible Note Financing   Momentum Public Relations Press Release: May 31, 2017 VANCOUVER, BC–(Marketwired – May 31, 2017) – Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB)(XETRA: ZSB) announced today a non-brokered private placement (the “Private Placement”) of convertible notes (“Notes”) for gross proceeds […]

Read more

Sirona Biochem (SBM:tsxv) Announces Keloid Data Accepted for Presentation to the Society of Investigative Dermatology

Sirona Biochem (SBM:tsxv) Announces Keloid Data Accepted for Presentation to the Society of Investigative Dermatology

Sirona Biochem Announces Keloid Data Accepted for Presentation to the Society of Investigative Dermatology (SID) Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) (XETRA: ZSB) (the “Company“) announced today that it has been accepted to present recent data at the 76th Annual Society of Investigative Dermatology (SID) […]

Read more

Rising Popularity of Anti-Wrinkle Products Fuels Asia, Europe, and South America Anti-Aging Market

Rising Popularity of Anti-Wrinkle Products Fuels Asia, Europe, and South America Anti-Aging Market

Rising Popularity of Anti-Wrinkle Products Fuels Asia, Europe, and South America Anti-Aging Market This press release was orginally distributed by SBWire Albany, NY — (SBWIRE) — 02/13/2017 — A new Transparency Market Research report states that the Asia, Europe, and South America anti-aging market was valued at US$15.3 […]

Read more

The 2017 Standards of Medical Care in Diabetes: an update from the ADA

The 2017 Standards of Medical Care in Diabetes: an update from the ADA

The 2017 Standards of Medical Care in Diabetes: an update from the ADA   The American Diabetes Association (ADA) has released the 2017 update to its Standards of Medical Care in Diabetes (Standards).1 The document is reviewed each year by a multidisciplinary committee of experts in diabetes care, […]

Read more

Sirona Biochem Announces Convertible Note Financing

Sirona Biochem Announces Convertible Note Financing

VANCOUVER, BC–(Marketwired – January 31, 2017) – Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) (XETRA: ZSB) announced today a non-brokered private placement (the “Private Placement”) of convertible notes (“Notes”) for gross proceeds of up to $600,000. Each Note will be convertible at the option of the holder into one common […]

Read more

Sirona Biochem (SBM:tsxv) CEO’s Report on Progress

Sirona Biochem (SBM:tsxv) CEO’s Report on Progress

Sirona Biochem CEO’s Report on Progress – Momentum Public Relations – Press Release: December 8, 2016 Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) (XETRA: ZSB) today provided a business update. Dear Shareholders, The following is an update on our progress in 2016 and our plans for […]

Read more

The Holy Grail of Skin Whitening Products – Expert Panel Discussion with Sirona Biochem

The Holy Grail of Skin Whitening Products – Expert Panel Discussion with Sirona Biochem

  Sirona Biochem – The Holy Grail of Skin Whitening Products – Momentum Public Relations – September 22, 2016 Sirona Biochem (SBM:tsxv) is a proactive development and discovery stage based biotech firm with an R&D lab situated in Paris, France. The biotechnology enterprise is headquartered in Vancouver, […]

Read more
Page 1 of 3123
Please wait...

Knowledge is Power

Knowledge is a necessity for all savvy investors. To achieve great CONSISTENT returns, smart investors know they need all the information they can get. We have your information!